MedPath

Multi-institutional, prospective study of a combination therapy with androgen deprivation and external beam radiation therapy for hormone-sensitive metastatic prostate cancer

Not Applicable
Conditions
Prostate cancer
Registration Number
JPRN-UMIN000033226
Lead Sponsor
Tohoku University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

1, Had a prior malignancy. (Any other cancer for which treatment has been completed >= 5 years is allowed). 2, Other pathological findings except for aciner adenocarcinoma. 3, Use of steroid agents

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Biochemical progression free survival
Secondary Outcome Measures
NameTimeMethod
Overall survival Clinical progression-free survival Cancer specific survival Quality of life Adverse events
© Copyright 2025. All Rights Reserved by MedPath